ecopipam has been researched along with mdl 100907 in 1 studies
Studies (ecopipam) | Trials (ecopipam) | Recent Studies (post-2010) (ecopipam) | Studies (mdl 100907) | Trials (mdl 100907) | Recent Studies (post-2010) (mdl 100907) |
---|---|---|---|---|---|
147 | 18 | 34 | 1,241 | 65 | 539 |
Protein | Taxonomy | ecopipam (IC50) | mdl 100907 (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0048 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hicks, PB; Richter, TJ; Trompler, RA; Wadenberg, ML; Young, KA; Zavodny, RA | 1 |
1 other study(ies) available for ecopipam and mdl 100907
Article | Year |
---|---|
A novel computer-controlled conditioned avoidance apparatus for rats.
Topics: Amphetamines; Animals; Antipsychotic Agents; Avoidance Learning; Benzazepines; Clozapine; Computers; Cross-Over Studies; Dopamine Antagonists; Fluorobenzenes; Haloperidol; Male; Physical Conditioning, Animal; Piperidines; Raclopride; Rats; Rats, Sprague-Dawley; Salicylamides; Serotonin Antagonists; Serotonin Receptor Agonists | 1997 |